Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removed the disease name 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' from the Study Details page. This reduces explicit disease labeling and related-topic references on the page.
    Difference
    0.1%
    Check dated 2026-01-02T20:16:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a topic and linked to MedlinePlus Genetics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-26T16:27:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing trial sites by region (Arizona, Colorado, Connecticut, Kansas, Texas, Virginia, New South Wales, Queensland, South Australia, Victoria, Western Australia, Alberta, Ontario, Quebec) and updated the page to Revision: v3.3.3. Removed several location-specific subsections (e.g., Arizona Locations, Colorado Locations, Connecticut Locations, Kansas Locations, Texas Locations, Virginia Locations, New South Wales Locations, Queensland Locations, South Australia Locations, Victoria Locations, Western Australia Locations, Alberta Locations, Ontario Locations, Quebec Locations).
    Difference
    0.7%
    Check dated 2025-12-19T10:48:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new publication citation about modifying belantamab mafodotin dosing in DREAMM-7 and DREAMM-8 was added, and the prior Blood Advances citation for the same topic was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-12T06:28:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2 with no visible changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T02:23:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.1 and removed the previous PubMed sourcing phrasing.
    Difference
    0.0%
    Check dated 2025-11-20T22:17:36.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.